ArticleJournal of inorganic biochemistry2026
Impact of N-terminal acetylation on Cu(I) coordination by alpha synuclein protein.
Article in Journal of inorganic biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Amyloid aggregation of alpha-synuclein (AS) protein is associated with Parkinson's disease. Physiologically, AS plays a crucial role in the uptake, storage, and recycling of neurotransmitter vesicles. AS has three independent binding sites for Cu(II) and Cu(I) ions. N-terminal acetylation of AS impacts the highest-affinity site of Cu, encompassing the first five residues; it prevents Cu(II) coordination, enhances Cu(I) binding affinity, raises its redox potential, and extends the α-helix to the first ten residues. In this study, X-ray absorption spectroscopy and electronic structure calculations are employed to provide a detailed molecular description of the highest affinity Cu(I) binding site in AS, both in the acetylated AS (AcAS) and non-acetylated forms of the protein. The roles of methionine residues Met1 and Met5 in Cu(I) binding are also evaluated using peptide fragment models. Our findings indicate that in both cases, the coordination sphere is tetracoordinated, with the two sulfur atoms from Met1 and Met5 serving as the primary anchors for Cu(I) coordination. At the same time, Met1 plays a crucial role in stabilizing Cu(I). While both complexes include the carboxylate oxygen of Asp2, a key difference lies in the fourth ligand: the Cu(I)-AS complex utilizes the N-terminal group, whereas the Cu(I)-AcAS complex uses a carbonyl oxygen from the N-terminal acetyl group. These results provide deeper insights into how acetylation impacts the chemical properties of the high-affinity copper binding site in AS and contribute to a better understanding of the role of Cu(I) binding in the physiological function of AS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.